Home
Mail
News
Sport
Finance
Celebrity
Style
Weather
Mobile
Messenger
Movies
More
Yahoo
Mail
News
Market Data
Crypto
Bank of England
Money Matters
Property
Top Stocks
Work & Management
Industry News
Brexit
My Portfolio
My Screeners
Watchlists
Videos
UK markets closed
FTSE 100
8,213.49
+41.34
(+0.51%)
FTSE 250
20,164.54
+112.21
(+0.56%)
AIM
771.53
+3.42
(+0.45%)
GBP/EUR
1.1652
-0.0031
(-0.26%)
GBP/USD
1.2546
+0.0013
(+0.11%)
Bitcoin GBP
50,817.77
+1,760.07
(+3.59%)
MONEY
Best savings accounts that offer above inflation rates
Where to find a top-rated deal that works for you
Ekso Bionics Holdings, Inc. (EKSO)
NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
1.3100
+0.0200
(+1.55%)
At close: 04:00PM EDT
Summary
Chart
Conversations
Statistics
Historical data
Profile
Financials
Analysis
Options
Holders
Sustainability
Show
:
Income statement
Balance sheet
Cash flow
Annual
Quarterly
Income statement
All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
18,279
18,279
12,912
11,246
8,882
Cost of revenue
9,200
9,200
6,698
4,497
3,812
Gross profit
9,079
9,079
6,214
6,749
5,070
Operating expenses
Research development
5,025
5,025
3,626
2,549
2,474
Selling general and administrative
19,166
19,166
18,144
18,028
15,454
Total operating expenses
24,191
24,191
21,770
20,577
17,928
Operating income or loss
-15,112
-15,112
-15,556
-13,828
-12,858
Interest expense
302
302
156
113
139
Total other income/expenses net
216
216
632
4,177
-2,828
Income before tax
-15,198
-15,198
-15,080
-9,764
-15,825
Income from continuing operations
-15,198
-15,198
-15,080
-9,764
-15,825
Net income
-15,198
-15,198
-15,080
-9,764
-15,825
Net income available to common shareholders
-15,198
-15,198
-15,080
-9,764
-15,825
Basic EPS
-1.12
-
-1.16
-0.80
-2.21
Diluted EPS
-1.12
-
-1.16
-0.88
-2.21
Basic average shares
13,544
-
12,962
12,193
7,164
Diluted average shares
13,544
-
12,962
12,269
7,164
Data disclaimer
Help
Suggestions
Terms
and
Privacy Policy
Privacy dashboard
About our ads
© 2024 Yahoo. All rights reserved.